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Abstract. This study aimed to find  out the potential 
of ethanol extract in rambutan seed to reduce the risk 
factors of cardiovascular disease by using animal 
model on diabetes-type 2 (DM-2). The animals used 
for this study were 3-4 months old male wistar mice 
with 20-25 grams weight. The diabetes mellitus 
induction type 2 to the animal model was performed 
through the administration of high fat diet for 4 
weeks followed by the daily dosage of Streptozotocin 
(STZ) 40 mg/kgbw and it was repeated for 4 times in 
the last week of induction. The administration of 70% 
ethanol extract of Binjai rambutan seed (Naphelium 
lappaceum L.) was done in Carboxy Methyl Cellulose 
0.5% and metformin as positive control. The result 
indicated that 70% ethanol extract of Binjai 
rambutan seeds had a significant effect on the 
atherosclerosis index (p <0,01) and all lipid profile 
parameters. The Binjai rambutan seed extract at 19.2 
mg/kgbw dose was the most effective to decrease the 
atherosclerosis index, total cholesterol, triglyceride, 
low density lipoprotein, and malodialdehyde and to 
increase high density lipoprotein and super oxide 
dismutase of mice blood serum. It can be concluded 
that the rambutan seed extract at the dose of 19.2 
mg/kgbw had the potential to reduce the risk of 
cardiovascular diabetes in mice by increasing lipid 
fraction and decreasing oxidative stress. 
 
Keywords: atherosclerotic index, binjai rambutan 
seed (Naphelium lappecium L.), diabetes mellitus, lipid 
profile 
 
INTRODUCTION 
 
Many cases of cardiovascular diseases in most 
developing countries including Indonesia cause 
morbidity and mortality and it requires substantial 
amount of treatment. Cardiovascular disease is non-
Communicable Diseases (NCDs) that causes the main 
death in South East Asia. NCDs data profile in 2014 
showed that 71% of 1,551,000 deaths in Indonesia were 
attributed to NCDs. Cardiovascular Disease (CVDs) was 
the biggest leading cause of death among 4 major NCDs 
with 37% of deaths followed by cancer (13%), DM 
(10%) and Chronic Respiratory Disease (CRD) was by 
5% [1]. Chronic DM is also a source of various risk 
factors causing CVDs either traditinal or non-traditional 
risk factors such as hypecholesterolemia, hypertension, 
insulin resistance and hyperglycemia. 
The DM-2 patient prevalence dominates the cases of 
DM, approximately 80% of the DM cases. DM-2 is a 
disease caused by metabolic disorders which are 
characterized by symptoms of hyperglycemia because of 
the insulin resistance. Glucose limitation in the cells 
caused by the insulin resistance and leads to a 
disturbance on the lipid metabolic balance in most of 
human body tissue. Insulin resistance in fatty tissues 
obstructs lipogenesis and increases lipolysis. This will 
trigger glucotoxicity followed by lipotoxicity and leads 
to the increase of risk factors for cardiovascular disease, 
for example the increase of total cholesterol (TC), 
triglyceride (TG), and low density lipoprotein (LDL) 
levels and the decrease of high density lipoprotein (HDL) 
levels. Despite as  a source of dyslipidemia, the increase 
of blood sugar levels can trigger oxidative stress and lead 
to the production of Reactive Oxygen Species (ROS) 
through the glucose autooxidation pathway. 
Atherosclerosis is as a cause of various cardiovascular 
diseases, it is resulted from chronic inflammatory 
reactions that involves Low Density Lipoproteine (LDL) 
and it is oxidized to foam cell macrophages in the sub 
endothelial vessel layer. Therefore, chronic DM patients 
have the potential to increase the LDL oxidation rate, 
thus having more risks of atherosclerosis and CVD 
compared to those with ordinary risk factors [2]. 
Phenolic of Rambutan seed methanol extract  is 124 
mg GAE/g DW (Garlic Acid Equivalent, GAE; Dried 
Weight, DW) and DPPH scavenging activity  is 383 mg 
VCEAC/g DW (Vitamin C Equivalent Antioxidant 
Capacity, VCEAC) [3]. It was also reported that 
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rambutan seed extract from the cultivar Sichompu of 
rambutan inhibited ROS formation [4]. Dry rambutan 
seed contains of a phytochemical with antioxidant 
characteristic (in mg/100g) such as saponin (2.10±0.05),  
alkaloid (1.95±0.02), HCN (0.00±0.00), tannin 
(0.28±0.01), phytate (0.77±0.03), phenol (0.41±0.09), 
oxalate (0.19±0.01), and flavonoids (1.63±0.32)[5], there 
are pretty much alkaloid in the rambutan seed extract. A 
previous study on the alkaloid test could inhibit 3T3 the 
preadipocyte differentiation. It was also reported that in 
vivo test in mice with HFD showed that the component 
could inhibit adiposity, obesity and body fat 
accumulation,  which was characterized by the decreased 
levels of TC, TG, and LDL and the increase of HDL [6]. 
Atherogenic index (AI) of Plasma is LDLc/HDLc that 
can be used as a regular monitoring index of CVD in 
every day practice, especially for people with 
cardiovascular risk factors [7]. Based on the previous 
studies, it is predicted that 70% of ethanol extract in 
rambutan seed is anti hyperlipidemic and rich of 
antioxidant. Thus, this study aimed to determine the 
potential of ethanol extract in rambutan seed for 
decreasing the atherogenic index in mice with DM-2. 
The supporting parameters in this study included the 
decrease of lipid serum profile including LDL and HDL 
levels, oxidative stress levels including SOD and MDA. 
 
METHOD 
 
Research Design  
This study employed Completely Randomized 
Design with 6 treatments and 4 repetitions. It used 24 
mice (Mus musculus L.) Strain Balb-C, they were 2-3 
months old and their weight were 20-30 g , around 20 
mice were induced with DM-2. The mice with DM-2 
were divided into 5 groups. For the positive control, they 
were given metformin dose 39 mg/kgbw (DMmet), and 
for the negative control without treatment (DMd0).  One 
group was given rambutan seed extract at a dose of 19.2 
mg/kgbw (DMd19) while another group was given 
rambutan seed extract at a dose of 23,4 mg/kgbw 
(DMd23). It was repeated until 4 times for each group. 
Meanwhile, a group of 4 mice was normal nonDM 
(nDM). The nDM and DMd0 groups were given 0.5% 
CMC as placebo. The treatments of ethanol extract in 
rambutan seed, metformin and CMC were given orally at 
a dosage of 0.5 ml for 30 days. 
 
Herbal Extraction, animal model induction and blood 
serum preparation  
Rambutan seed extraction was done by using a 
maceration method with 70% ethanol solvent referred to 
Vongsak et al. [8]. The induction of DM-2 to the animal 
model was performed by giving the High Fat Diet (HFD) 
followed by the injection of STZ in multiple low dosages 
referred to Zang et al., [9]. The Streptozotocin used was 
Bio-world, USACat 714992 CAS 18883-66-4.
Blood was taken from the heart of the fasting mice to 
which dislocation of the neck was previously performed. 
Blood was centrifuged at 3000 rpm for 15 minutes to 
obtain a clear supernatant. The measurements of SOD 
and MDA were performed immediately on fresh serum, 
while the remaining serum was stored at -80°C for the 
measurement of lipoprotein level. 
 
Techniques of Measurement 
FBG level was measured by using Accutrend Plus 
Cholesterol Meter from Roche. The cLDL Reagent 
precipipation measurement to determine the cLDL level 
was performed using CHOD-PAP method on 
photometric systems, DiaSys, Germany. Meanwhile, the 
HDLc measurement was performed using Differential 
Precipitation Enzymatic Cororymetric Test Endpoint 
from Glory Diagnostic, with Reagent from Glory 
Diagnostic, Spanyol, GD-HDLP80 and GD-
HDLP180.Measurement of serum cHDL level by using 
Differential Precipitation Enzymatic Colorymetric Test 
Endpoint method.  
SOD activity was determined spectrophotometrically 
by using Superoxide Dismutase (SOD) Assay Kit 
Catalogue No: E-BC-K020. SOD activity was measured 
by the WST-1 method, the measurement procedure 
followed by the protocol attached to the kit and the 
measurement used a spectrofotometer at λ 450nm. The 
level of MDA was measured by TBARS method. TBA 
from Sigma Aldrich. Spectrophotometric determination 
of MDA-TBA withUV-Vis spectrophotometer at λ 533 
nm at room temperature, the principal measurement 
refers to Setin et al.[10]. AI was calculated by dividing 
LDLc with HDLc level. 
 
Data Analysis  
Data of the effect of 70% of ethanol extract in 
rambutan seed on the levels of LDLc, HDLc, MDA, 
SOD dan AI which met the parameter data rules (being 
distributed and having homogen variance values) were 
analyzed using One Way Anova test, to find out the 
significant mean. When the result was significant, further 
test of Duncant Multiple Range Test (DMRT) was 
performed with p=0,05. If the data did not meet the 
parameter rules, Mann-Whiteney U-Test was performed. 
The statistic test was done using SPSS program ver.16.0  
 
RESULT 
 
HFD diet and STZ injection succeeded in increasing 
the blood sugar as well, FBG level was increased from 
101.75±31.521mg/dL in normal mice to 
420.19±20.347mg/dL in mice with DM. The mean of 
DM-2 FBG level were at least 285mg/dl (complete data 
not shown). Statistic result of LDL and HDL serum level 
shown at figure 1,  SOD and MDA level at figure 2, and 
AI at figure 3. 
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Figure 1: The Effect of Rambutan Seed Extract on Characteristic Mice Serum A. LDL B. HDL 
Note: Different label is significant in DMR t test ά=5%. 
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Figure 2: The Effect of Rambutan Seed Extract on the Characteristic Mice Serum A. SOD B. MDA 
Note: Different label is significant in SOD DMRT test 5%  and MDA U-Mann Whiteney test ά=5%. 
 
 
 
 
 
 
Figure 3. The Effect of Rambutan Seed Extract on Atherosclerotic 
Index 
Note: Different label is significant in AI DMRT  test ά=5%. 
 
 
DISCUSSION 
  
The FBG of mice that received HFD and STZ 
injection in this research was increasing the blood sugar 
level up to 55% in diabetic category, FBG≥285mg/dl. 
This is in line with the required mice with DM by 
Alacron-Aguilar at FBG> 200mg/kgbw[11]. The level of 
FBG in mice with DM and administered with rambutan 
seed extract decreased significantly. The results of this 
study support the results of Soeng in 2015 in which the 
rambutan seed extract of 70% ethanol on pre-adipocyte 
3T3 cell culture is able to decrease α-glucosidase 
activity, thereby decreasing the blood glucose level. In 
addition, Soeng et al. also reported an anti-obesity effect 
of rambutan seed extract by decreasing G6PDH activity 
and TG levels. Moreover, 70% ethanol extract of 
rambutan seed is able to give much better effect than 
hexane fraction at the same concentration [12].  
The animal model of DMd0 showed high glucose 
levels, experiencing hyperlipidemia, increased MDA and 
decreased SOD. These data are consistent with the 
patient serum profile, the DM patients experienced 
hyperlipidemia and decreased SOD compared to normal 
individuals [13] and DM patients with high HBA1c 
(glycated hemoglobin) showed increasing MDA and 
decreasing SOD [14]. In DM-2 patients, the lipid profile 
significant increases except HDL cholesterol. It tends to 
decrease. Similarly, there is a significant decrease in 
antioxidant enzymes such as reduced glutathione, 
glutathione peroxides, glutathione reductase, and 
superoxide dismutase, except catalase as compared to the 
control subjects. Other findings showed that the level of 
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lipid peroxide (MDA) increased as per the increase in the 
blood glucose concentration [15]. 
The high ratio of LDL/HDL is associated with the 
risk of atherosclerosis. The higher the ratio, the higher 
the risk of atherosclerosis, which then known as the 
Atherosclerosis Index (AI). In this study, the 
administration of rambutan seed extract significantly 
decreases AI compared to DM mice. The value is similar 
with in mice receiving standard drug and normal mice. 
Hyperlipidemia accompanied by oxidative stress 
potentially triggers lipid peroxidation and endothelial 
dysfunction. Low Density Lipoprotein Cholesterol 
(LDLc) is a material which turns into non-self material if 
oxidized thus stimulating the inflammatory reaction and 
chronically having been able to develop into 
atherosclerosis [16].  
 
CONCLUSION 
 
Based on the result, it is concluded that 
administration of 70% alcohol extract of rambutan seed 
potentially lowers the risk of CVD in the DM patients 
because it decreases not only the level of blood glucose 
as the main factor, but also other proatherogenic 
conditions such as lowering the levels of LDL atheroma 
materials and improving oxidative stress by increasing 
the SOD enzymatic antioxidant. 
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